Anne Marie Cook
CIK 1320559 · Chief Legal Off. & Corp. Sec. · last filed 2026-02-12
Anne Marie Cook is a Chief Legal Off. & Corp. Sec. who has filed 31 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for PHAT, was dated Feb 12, 2026. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $919.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$919.4K
4
31
-$2.49M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHAT | Chief Legal Off. & Corp. Sec. | 88,660 | $10.37 | $919.4K | $0 | 4 | 2026-02-12 |
| Sage Therapeutics, Inc. (SAGE) Delisted | SVP, GC & Secretary | 24,040 | $8.68 | $208.7K | -$2.49M | 21 | 2024-08-07 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | SVP, General Counsel | — | — | — | $0 | 5 | 2015-08-06 |
| VIACELL INC (VIAC) Delisted | General Counsel, SVP | — | $29.58 | — | $0 | 1 | 2007-03-09 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-12 | PHAT | Mixed | +1,926 | -$19.7K | EDGAR |
| 2026-01-02 | PHAT | Grant (A) | +75,345 | $0 | EDGAR |
| 2025-12-19 | PHAT | Mixed | +9,667 | -$118.3K | EDGAR |
| 2025-06-24 | PHAT | Grant (A) | — | $0 | EDGAR |
| 2024-08-07 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +8,997 | -$40.3K | EDGAR |
| 2024-02-15 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | +11,250 | $0 | EDGAR |
| 2023-11-30 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +2,826 | -$22.6K | EDGAR |
| 2023-02-15 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-07 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +1,870 | -$43.3K | EDGAR |
| 2022-02-15 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |